BackTCI GENE Overview

TCI GENE Total Liabilities

TCI GENE's total liabilities is $110M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$112.92M
↓ 36.74% YoYΔ $-65.59M vs prior year quarter

Peer trimmed avg / median

Loading

TCI GENE Total Liabilities History

Loading

TCI GENE vs. peers: Total Liabilities Comparison

Loading

TCI GENE Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TCI GENE (6879.TWO) FAQ

TCI GENE posts a total liabilities of $110M as of June 2026. That compares with $180M in the prior-year period — down 36.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, TCI GENE's total liabilities was $180M. The latest reading is $110M — a 36.7% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of TCI GENE's financial statement story. At $110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 6879.TWO's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; TCI GENE's other metric pages and overview cover the third.

Judging TCI GENE against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total liabilities easier to interpret. Start with $110M here, then scan peer and history charts to see if the gap is persistent.